Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Potential of Carnosine Supplementation in Reducing the Cardiometabolic Risk: a Double-blind, Placebo-controlled Trial

NCT02686996 is registered in ClinicalTrials.gov with Monash University as lead sponsor.

NCT NCT02686996
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02686996 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Potential of Carnosine Supplementation in Reducing the Cardiometabolic Risk: a Double-blind, Placebo-controlled Trial
Lead sponsor
Monash University
Phase
Not applicable
Overall status
Unknown status
Start date
February 13, 2017
Completion date
June 12, 2020
Enrollment
84 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

insulin sensitivity